Free Trial

eFFECTOR Therapeutics (EFTRW) News Today

eFFECTOR Therapeutics logo

EFTRW Latest News

eFFECTOR Therapeutics (Nasdaq:EFTRW) Headline
Trading was temporarily halted for "EFTRW" at 08:04 AM with a stated reason of "News pending."...
eFFECTOR Therapeutics Inc. Warrant
eFFECTOR Therapeutics (Nasdaq:EFTRW) Headline
Trading was temporarily halted for "EFTRW" at 07:01 PM with a stated reason of "News pending."...
eFFECTOR Therapeutics Announces Reverse Stock Split
eFFECTOR updates Phase 1/2 data for breast cancer therapy
eFFECTOR Therapeutics Inc.
Get eFFECTOR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EFTRW and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EFTRW Media Mentions By Week

EFTRW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EFTRW
News Sentiment

0.00

1.03

Average
Medical
News Sentiment

EFTRW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EFTRW Articles
This Week

0

0

EFTRW Articles
Average Week

Get the Latest News and Ratings for EFTRW and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:EFTRW) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners